Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From ABOGEN INC

Cash, Lights, Go: Shanghai Takes On Boston In Latest Policy Appeal To Biopharma

Developers of antibodies, novel vaccines and cell and gene therapies are all slated to get funding support as Shanghai unleashes a flurry of incentives and policies to lead China’s push to become a global biopharma powerhouse.

China Policy

How A Small Chinese Biotech Is Taking On mRNA Vaccine Giants

Originated by a Suzhou-based biotech founded two years ago and now being jointly developed with WalVax, China’s first homegrown mRNA COVID-19 vaccine is now entering the final stages of development.

China Coronavirus COVID-19

IP Waiver Might Kick-Start China's Novel COVID-19 Vaccine Effort

As the US responds to calls to waive intellectual property rights related to COVID-19 vaccines, China is already moving ahead with some of its own mRNA candidates.

Coronavirus COVID-19 Intellectual Property
See All

Company Information

UsernamePublicRestriction

Register